Alle Filter zurücksetzen
Kategorien
  • Pharma / Gesundheit
  • Pharmaindustrie / Medikamente
  • Schmerzen / Migräne / Analgetika
  • Filter zurücksetzen
Regionen/Länder
  • Europa
  • Belgien
  • Bosnien-Herzegowina
  • Bulgarien
  • Dänemark
  • Deutschland
  • Estland
  • Finnland
  • Frankreich
  • Griechenland
  • Irland
  • Italien
  • Kroatien
  • Lettland
  • Litauen
  • Mazedonien
  • Niederlande
  • Norwegen
  • Österreich
  • Poland
  • Portugal
  • Rumänien
  • Russian Federation
  • Schweden
  • Schweiz
  • Serbien
  • Slowakei
  • Slowenien
  • Spanien
  • Tschechien
  • Türkei
  • Ukraine
  • Ungarn
  • Vereinigtes Königreich
  • Weißrussland
  • Weißrussland
  • Asien / Pazifik
  • China
  • Hong Kong
  • Indien
  • Indonesien
  • Japan
  • Kasachstan
  • Malaysia
  • Neuseeland
  • Pakistan
  • Philippinen
  • Singapur
  • Südkorea
  • Taiwan
  • Thailand
  • Usbekistan
  • Vietnam
  • Mittlerer Osten / Afrika
  • Ägypten
  • Algerien
  • Iran
  • Israel
  • Kamerun
  • Kenia
  • Marokko
  • Nigeria
  • Saudi Arabien
  • South Africa
  • Tunesien
  • Vereinigte Arabische Emirate
  • Nordamerika / USA
  • Kanada
  • United States
  • Australien
  • Mittel- / Südamerika
  • Argentinien
  • Bolivien
  • Brasilien
  • Chile
  • Costa Rica
  • Kolumbien
  • Mexiko
  • Peru
  • Uruguay
  • Venezuela
  • Filter zurücksetzen
Herausgeber
  • Biopharm Reports
  • Canadean
  • Datamonitor
  • Euromonitor
  • GBI Research
  • Global Markets Direct
  • GlobalData
  • Life Science Analytics
  • Technavio
  • Filter zurücksetzen
Sprache
  • Englisch
  • Filter zurücksetzen
Datum
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • Filter zurücksetzen
laedt

Marktanalyse - Analgesics in Austria

Euromonitor

Euromonitor

7 / 2012
31 Seiten
Typ: Marktanalyse
Sprache: Englisch
Regionen: Österreich
Verfügbarkeit: verfügbar

Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:

675,00 €*
PDF-Datei per E-Mail , versandkostenfrei


The category of analgesics was influenced by two important factors in 2011. Firstly, the strong flu season in Austria towards the end of 2010 led to increased consumption of analgesics. Within this, aspirin was very successful as Austrians tend to buy aspirin for relief from headaches, fever and other flu-related symptoms. Secondly, the strong performance of ibuprofen also had an impact on the positive development of analgesics. Recent studies in Austria revealed that ibuprofen is much more...

Euromonitor International's Analgesics in Austria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
ANALGESICS IN AUSTRIA

Euromonitor International

July 2012



LIST OF CONTENTS AND TABLES



Headlines

Trends

Switches

Competitive Landscape

Prospects

Category Data

Table 1 Sales of Analgesics by Category: Value 2006-2011

Table 2 Sales of Analgesics by Category: % Value Growth 2006-2011

Table 3 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011

Table 4 Analgesics Company Shares by Value 2007-2011

Table 5 Analgesics Brand Shares by Value 2008-2011

Table 6 Forecast Sales of Analgesics by Category: Value 2011-2016

Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Dr A & L Schmidgall AG in Consumer Health (austria)

Strategic Direction

Key Facts

Summary 1 Dr A & L Schmidgall GmbH & Co KG: Key Facts

Summary 2 Dr A & L Schmidgall GmbH & Co KG: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 3 Dr A & L Schmidgall GmbH & Co KG: Competitive Position 2011

Kwizda Pharma GmbH in Consumer Health (austria)

Strategic Direction

Key Facts

Summary 4 Kwizda Pharma GmbH: Key Facts

Summary 5 Kwizda Pharma GmbH: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 6 Kwizda Pharma GmbH: Competitive Position 2011

Wellness Co Gmbh, the in Consumer Health (austria)

Strategic Direction

Key Facts

Summary 7 The Wellness Co GmbH: Key Facts

Company Background

Production

Competitive Positioning

Summary 8 The Wellness Co GmbH: Competitive Position 2011

Executive Summary

Good Performance of Consumer Health

Hectic Lifestyles Compared With Health and Wellness

Multinationals Lead Sales

Pharmacists Prevail, Internet Retailing Growing

Modest Future Ahead

Key Trends and Developments

Busier Lifestyles Drive the Sales of Self-medication

Demographic Changes: Producers Increasingly Target Over 50s

Healthier Lifestyles As Philosophy of Living

Unhealthy Eating Habits Lead To High Obesity Rates

Pharmacies and Internet Important Channels of Distribution

Market Indicators

Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011

Table 9 Life Expectancy at Birth 2006-2011

Market Data

Table 10 Sales of Consumer Health by Category: Value 2006-2011

Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011

Table 12 Consumer Health Company Shares 2007-2011

Table 13 Consumer Health Brand Shares 2008-2011

Table 14 Penetration of Private Label by Category 2006-2011

Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011

Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011

Table 17 Forecast Sales of Consumer Health by Category: Value 2011-2016

Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements' Registration and Classification

Self-medication/self-care and Preventative Medicine

Switches

Summary 9 OTC - Switches 2009-2011

Definitions

Sources

Summary 10 Research Sources

*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.

Für Sie protokollierte Studien / Marktanalysen:
  zuletzt angesehene Studien: